The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

Research indicates that pneumonia occurs in 30% and intestinal blockage in 5% of schizophrenia patients on clozapine, ...

About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective ...

These side effects increase mortality, highlighting the need for better monitoring. Genetic testing could help identify high-risk patients. (Image: Pixabay/Gerd Altmann) About one-third of patients ...